Personalized therapy tests for the monitoring of chronic lymphocytic leukemia development

Por Rogalińska, Małgorzata, Góralski, Paweł, Błoński, Jerzy Z., Robak, Paweł, Barciszewski, Jan, Koceva-Chyła, Aneta, Piekarski, Henryk, Robak, Tadeusz, Kilianska, Zofia M.
Publicado no Oncol Lett (2017)

Toward personalized therapy for chronic lymphocytic leukemia: DSC and cDNA microarray assessment of two cases

Por Rogalińska, Małgorzata, Franiak-Pietryga, Ida, Błoński, Jerzy Z., Góralski, Paweł, Maciejewski, Henryk, Janus, Agnieszka, Robak, Paweł, Mirowski, Marek, Piekarski, Henryk, Robak, Tadeusz, Kiliańska, Zofia M.
Publicado em 2013

Subcutaneous versus intravenous bortezomib in patients with relapsed multiple myeloma: subanalysis of patients with renal impairment in the phase III MMY-3021 study

Por Moreau, Philippe, Pylypenko, Halyna, Grosicki, Sebastian, Karamanesht, Ievgenii, Leleu, Xavier, Rekhtman, Grigoriy, Masliak, Zvenyslava, Robak, Pawel, Esseltine, Dixie-Lee, Feng, Huaibao, Deraedt, William, van de Velde, Helgi, Arnulf, Bertrand
Publicado no Haematologica (2015)